Skip to main content

Human papillomavirus (HPV) vaccine hesitancy trends in the United States.

Publication ,  Conference
Boakye, EA; Abouelella, DK; Nair, M; Osazuwa-Peters, N
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boakye, E. A., Abouelella, D. K., Nair, M., & Osazuwa-Peters, N. (2022). Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Boakye, Eric Adjei, Dina K. Abouelella, Mrudula Nair, and Nosayaba Osazuwa-Peters. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Boakye, Eric Adjei, et al. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. JOURNAL OF CLINICAL ONCOLOGY. 2022.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences